the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� . .: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies." .
another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict .
it would likely look like what occurred in minnesota last year, when a